Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAP3K2

RBC: MEKK2 · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib88.30.53
Crizotinib83.70.58
Repotrectinib80.10.61
Nintedanib76.90.61
Ripretinib69.30.67
Pemigatinib67.20.72
Neratinib59.20.60
Bosutinib58.40.55
Ruxolitinib52.60.59
Infigratinib48.90.71
Sunitinib46.80.52
Midostaurin43.50.50
Baricitinib39.40.62
Pacritinib39.30.45
Apatinib38.20.70

Known variants

No variants catalogued.
Open in new tab